Pharmafile Logo
Pharmafocus logo
Advanced Search

The inspector calls

September 28, 2005
Research and Development

I have become a pharmacovigilance bore within my company, a prophet of doom. It is worse than that, because for …

Feature

Astellas launches Flomaxtra XL

September 27, 2005
Sales and Marketing

Astellas has launched Flomaxtra XL, a new treatment for the symptoms of BPH or benign prostatic hyperplasia.The condition is the …

News
Sains

Lilly increasing investment in UK R&D

September 23, 2005
Research and Development

 Lilly has opened a new  £26 million UK research facility, a move which underlines its commitment to developing medicines in …

News

Novartis pipeline promises cardiovascular advances

September 22, 2005
Research and Development

Novartis hopes to expand its presence in cardiovascular medicine with the filing next year of two potentially first-in-class products with …

News

US rejects Pfizer’s injectable Cox-II

September 22, 2005
Sales and Marketing

The FDA has denied approval for Pfizer's injectable pain drug Dynastat, delivering a fresh blow to the embattled Cox-II class …

News

NICE to review guidance on hypertension treatments

September 22, 2005
Research and Development

NICE has set up a specialist advisory group to review new data which could lead to thousands of heart patients …

News

Roche’s Tarceva approved in Europe

September 21, 2005
Sales and Marketing

News

Once a month osteoporosis pill launched

September 21, 2005
Sales and Marketing

News

New data gives Seretide upper hand in respiratory battle

September 20, 2005
Sales and Marketing

Seretide's domination in the global respiratory market looks set to be bolstered by a new head to head study with …

News

Biotechs back change to UK pricing system

September 16, 2005

The current UK medicines pricing system discriminates against smaller biotech companies, and should be altered to take this into account, …

News

New NHS leaders in Alzheimer’s research and development

September 15, 2005

A new NHS team has been set up to accelerate the development of new medical treatments for neurodegenerative conditions such …

News

National healthcare debate launched

September 15, 2005

The first of four major events aimed at stimulating debate about the future of healthcare in the community has been …

News

PCTs, points and their progress

September 15, 2005

The Quality and Outcomes Framework (QOF) is the cornerstone of the new GMS contract whereby practices achieve payment for achievement …

Feature

Handing over the reins of power

September 14, 2005
Sales and Marketing

From poetry to patronage, finding a new chief executive for any pharma or biotech company can be a complicated business, …

Feature

Dealing with the generic threat

September 14, 2005
Sales and Marketing

The looming spectre of generics is one which no pharma company with successful medicines on the market can afford to …

Feature

Postcode prescribing down to poor financial management, says report

September 13, 2005

Postcode prescribing will only be eradicated if PCTs and NHS Trusts improve their financial management, according to a new report.The …

News

Connecting with customers

September 13, 2005
Sales and Marketing

Great creative executions, those that have the 'wow' factor and stand out from the crowd, require long-term brand strategy and …

Feature

Exubera receives FDA vote of confidence

September 9, 2005
Research and Development, Sales and Marketing

Exubera, the first inhaled insulin treatment for diabetes, has moved a step closer to US approval following recommendation approval from …

News

Pfizer and Sanofi battle challenges on patents

September 8, 2005
Sales and Marketing

Two blockbuster drugs are facing key patent challenges on both sides of the Atlantic, with the outcome of the cases …

News

A far stricter code – but more scope for communication too

September 8, 2005
Sales and Marketing

A much tighter UK pharmaceutical industry code of practice looks set to be introduced shortly, with a broad range of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025